Diabete Type 2 Clinical Trials in Seoul
2 recruitingSeoul, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus
HypertensionDiabete Type 2
Hanlim Pharm. Co., Ltd.228 enrolled1 locationNCT07552389
Recruiting
Phase 3
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Diabete Type 2T2DMDM
Celltrion171 enrolled1 locationNCT07093476